Format

Send to

Choose Destination
J Pediatr Surg. 1995 Sep;30(9):1282-7.

Bleomycin therapy for cystic hygroma.

Author information

1
Division of Surgery, Princess Margaret Hospital for Children, Perth, Subiaco, Western Australia.

Abstract

Intralesional bleomycin injection was used as sclerosant therapy for sixteen patients with cystic hygroma. An excellent (complete clinical resolution) response was obtained in seven (44%) patients, a good (> 50% response) result in seven (44%), and a poor or no response in two (12%). Minor transient side effects (fever, vomiting, cellulitis, skin discoloration) were seen in six patients, and there were no serious side effects. The results suggest that bleomycin intralesional sclerosant is effective therapy for cystic hygroma, with response rates comparable to those of surgical removal, but with the advantage of avoiding inadvertent nerve damage and scarring.

PMID:
8523225
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center